The Summary Report of the 5th Collaborative Study by CSGMT/JEMMS, MMS, Mutation Res., 278, str. 83-98.
The Summary Report of the 5th Collaborative Study by CSGMT/JEMMS, MMS, Mutation Res., 278, pp. 83-98.
8 Prevajalska redakcija
RS
EMEA
Proučevani bolniki so imeli rezultate MMSE (Mini- Mental State Examination – kratek preizkus spoznavnih sposobnosti) med 10 in 24.
The patients studied had an MMSE (Mini-Mental State Examination) score of 10– 24.
9 Prevajalska redakcija
RS
EMEA
Bolniki, vključeni v to študijo, so imeli rezultat MMSE (Mini- Mental State Examination – kratek preizkus spoznavnih sposobnosti) med 10 in 20.
Patients involved in this study had an MMSE (Mini-Mental State Examination) score of 10– 20.
10 Prevajalska redakcija
RS
EMEA
MMSE ali " Mini- mental State Examination ") ob vključitvi je zdravljenje z memantinom v monoterapiji pokazalo izboljšanje v primerjavi s placebom, v obdobju 6 mesečnega zdravljenja (analiza opazovanih bolnikov, lestvice CIBIC- plus (" Clinician' s Interview- Based Impression of Change Plus Caregiver Input " oz.
The study showed beneficial effects of memantine treatment in comparison to placebo at 6 months (observed cases analysis for the clinican´s interview based impression of change (CIBIC-plus): p=0.025; Alzheimer´s disease cooperative study – activities of the daily living (ADCS-ADLsev): p=0.003; severe impairment battery (SIB): p=0.002).
11 Prevajalska redakcija
RS
EMEA
MMSE ali " Mini- mental State Examination ") ob vključitvi je zdravljenje z memantinom v monoterapiji pokazalo izboljšanje v primerjavi s placebom, v obdobju 6 mesečnega zdravljenja (analiza opazovanih bolnikov, lestvice CIBIC- plus - (" Clinician' s Interview- Based Impression of Change Plus Caregiver Input " oz.
The study showed beneficial effects of memantine treatment in comparison to placebo at 6 months (observed cases analysis for the clinician´s interview based impression of change (CIBIC-plus): p=0.025; Alzheimer´s disease cooperative study – activities of daily living (ADCS-ADLsev): p=0.003; severe impairment battery (SIB): p=0.002).
12 Prevajalska redakcija
RS
EMEA
MMSE ali " Mini- mental State Examination ")) ob vključitvi je zdravljenje z memantinom v monoterapiji pokazalo izboljšanje v primerjavi s placebom, v obdobju 6 mesečnega zdravljenja (analiza opazovanih bolnikov, lestvice Vtis sprememb na osnovi kliničnega intervjuja (CIBIC- plus - " Clinician' s Interview- Based Impression of Change Plus Caregiver Input "): p=0, 025; Vprašalnik vsakodnevnih aktivnosti (ADCS- ADLsev oz.
The study showed beneficial effects of memantine treatment in comparison to placebo at 6 months (observed cases analysis for the clinician’ s interview based impression of change (CIBIC-plus): p=0.025; Alzheimer´s disease cooperative study- activities of daily living (ADCS-ADLsev): p=0.003; severe impairment battery (SIB): p=0.002).